Axogen
Yahoo Finance • 12 months ago
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Axogen, Inc. ALACHUA and TAMPA, Fla., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducemen... Full story
Yahoo Finance • last year
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
ALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, Chairman... Full story
Yahoo Finance • last year
Q3 2023 AxoGen Inc Earnings Call
Participants Karen Zaderej; Chairman of the Board, President, & CEO; Axogen, Inc. Pete Mariani; CFO & EVP; Axogen, Inc. Adanna Alexander; IR; Russo Partners LLC Mike Sarcone; Analyst; Jefferies Group Mike Kratky; Analyst; Leerink Part... Full story
Yahoo Finance • last year
Axogen Inc (AXGN) Reports 12% Revenue Growth in Q3 2023
Axogen Inc (NASDAQ:AXGN) reported a 12% increase in revenue for Q3 2023, amounting to $41.3 million. The company's net loss for the quarter was $4.1 million, slightly lower than the $4.3 million net loss in Q3 2022. Gross margin for the qu... Full story
Yahoo Finance • last year
Axogen, Inc. Reports 2023 Third Quarter Financial Results
ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and b... Full story
Yahoo Finance • last year
Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023
ALACHUA, Fla. and TAMPA, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report th... Full story
Yahoo Finance • last year
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
ALACHUA, Fla. and TAMPA, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the full launch of Ax... Full story
Yahoo Finance • last year
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
ALACHUA, Fla. and TAMPA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the successful first w... Full story
Yahoo Finance • 2 years ago
Axogen to Participate at JMP Securities Life Sciences Conference
Axogen, Inc. ALACHUA, Fla. and TAMPA, Fla., May 12, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Peter... Full story
Yahoo Finance • 2 years ago
Axogen, Inc. Reports 2023 First Quarter Financial Results
ALACHUA, Fla. and TAMPA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and bu... Full story
Yahoo Finance • 2 years ago
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
ALACHUA, Fla. and TAMPA, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report f... Full story
Yahoo Finance • 2 years ago
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
ALACHUA, Fla. and TAMPA, Fla., March 14, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and... Full story
Yahoo Finance • 2 years ago
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
ALACHUA, Fla. and TAMPA, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Ma... Full story
Yahoo Finance • 2 years ago
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
ALACHUA, Fla. and TAMPA, Fla., March 02, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report f... Full story
Yahoo Finance • 2 years ago
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jen... Full story
Yahoo Finance • 2 years ago
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited... Full story
Yahoo Finance • 2 years ago
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer
DENVER, Jan. 9, 2023 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended December 31, 2022. The preliminary results have not been audi... Full story
Yahoo Finance • 2 years ago
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
ALACHUA, Fla. and TAMPA, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the independent public... Full story
Yahoo Finance • 2 years ago
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, ch... Full story
Yahoo Finance • 2 years ago
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Re... Full story
